[EN] COMPOUNDS AND THEIR METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2014079150A1
公开(公告)日:2014-05-30
Provided are compounds of formula (I), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.
[EN] COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES AS GLUTAMINASE INHIBITORS FOR TREATING CANCERS THEREOF<br/>[FR] COMPOSÉS, COMPOSITIONS PHARMACEUTIQUES ET UTILISATIONS DES COMPOSÉS EN TANT QU'INHIBITEURS DE GLUTAMINASE POUR LE TRAITEMENT DE CANCERS ASSOCIÉS
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2014079136A1
公开(公告)日:2014-05-30
Provided are compounds of formula (I), wherein X, Y, Z, W, m, n, o, p, R1, R2 and R6 are defined as in the description. Pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof are also provided.
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.
本文描述了抑制谷氨酰胺酶的化合物和组合物。本文还描述了使用抑制谷氨酰胺酶的化合物治疗癌症的方法。
US9029531B2
申请人:——
公开号:US9029531B2
公开(公告)日:2015-05-12
COMPOUNDS AND THEIR METHODS OF USE
申请人:Lemieux Rene M.
公开号:US20140142081A1
公开(公告)日:2014-05-22
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.